Our team has supported exceptional
early-stage ventures
Our 35-year history has demonstrated success in selecting
partners and supporting commercial goals.
Our team has supported exceptional early-stage ventures
Our 35-year history has demonstrated success in selecting
partners and supporting commercial goals.
Key Activities and Outcomes
Clinical stage oncology therapeutics
• Corporate identity
• Investor targeting strategy
• PR strategy and support
• Clinical conference support
$165M
Private
Placement
Pre-commercial (rare disease)
hematology biotech
• Patient journey mapping
• Clinical planning support
• Early-stage product positioning strategy
• Pricing and forecast modeling
$825M
Acquisition by
Bioverativ
Commercial-stage transplant diagnostics
• Portfolio alignment strategy
• Corporate and product identity
• Investor strategy
$40M
IPO
Pre-commercial diagnostics firm
• Corporate identity
• Target selection support
• Launch strategy
• Product brand development
